Brystundersøkelse

Brystvortene, væsking, veiviser

Hva kan det være?

Pasientinformasjon

Gynekologi

Kliniske kapitler

Håndboken

Norsk Elektronisk Legehåndbok

Hva er væsking fra brystvortene?

Forekomst

Hvorfor siver det væske?

Hva kan årsaken være?

Vanlige årsaker

Sjeldnere årsaker

Hva kan du gjøre selv?

Når bør du søke lege?

Hva gjør legen?

Sykehistorien

Legeundersøkelsen

Andre undersøkelser

Henvisning til spesialist eller sykehus

Sekresjon fra brystvorte

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=22962879[uid]

Huang W, Molitch ME. Evaluation and management of galactorrhea. Am Fam Physician. 2012 Jun 1;85(11):1073-80. PMID: 22962879. 

--&gt; https://www.uptodate.com/contents/nipple-discharge?source=search_result&amp;search=galactorrhea&amp;selectedTitle=1~147

Golshan M. Nipple discharge. UpToDate, last updated Apr 08, 2020. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=Obstet Gynecol Surv [ta]+AND+61[vol]+AND+278[page]

Hussain AN, Policarpio C, Vincent MT. Evaluating nipple discharge. Obstet Gynecol Surv 2006; 61:278. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=16034013[uid]

Santen RJ, Mansel R. Benign breast disorders. N Engl J Med. 2005;353(3):275–285. PMID: 16034013. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=18404390[uid]

Molitch ME. Drugs and prolactin. Pituitary. 2008;11(2):209–218. PMID: 18404390. 

Coker F, Taylor D. Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management. CNS Drugs. 2010;24(7):563–574. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=BMC Psychiatry[ta]+AND+10[vol]+AND+26[page]

Johnsen E, Kroken RA, Wentzel-Larsen T, Jørgensen HA. Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. BMC Psychiatry. 2010;10:26. 

Biller BM. Hyperprolactinemia. Int J Fertil Womens Med 1999; 44: 74-7. 

Alikasifoglu A, Kandemir N, Akalan N, Yordam N. Pituitary adenoma associated with gigantism and hyperprolactinemia. Pediatr Neurosurg 2001; 35: 325-8. 

Raber W, Gessl A, Nowotny P, Vierhapper H. Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin Endocrinol Oxf 2003; 58: 185-91. 

Serri O, Chik CL, Ur E, Ezzat S. Diagnosis and management of hyperprolactinemia. CMAJ 2003; 169: 575-81. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=21296991[uid]

Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–288. PMID: 21296991. 

--&gt; http://dx.doi.org/10.1002/bjs.10125

Waaijer L, Simons JM, Borel Rinkes IH, et al. Systematic review and meta-analysis of the diagnostic accuracy of ductoscopy in patients with pathological nipple discharge. Br J Surg 2016. doi:10.1002/bjs.10125 

De Luis DA, Becerra A, Lahera M, Botella JI, Valero MA, Varela C. A randomized cross-over study comparing cabergoline and quinagolide in the treatment of hyperprolactinemic patients. J Endocrinol Invest 2000; 23: 428-34. 

Væsking fra brystvortene, veiviser

Del pasientinformasjon